
---
title: "JNJ"
subtitle: "Stock Analysis by ChatGPT"
date: 2023-08-27T09:07:53
draft: true
tags: ['exchange offer', 'strategic investments', 'market presence', 'business operations', 'litigation concerns']
author: Friday Wall
---

score:26
### Chances:
1. J&J's exchange offer for Kenvue was a big win and a huge hit with shareholders.
2. J&J-backed startup raises $150M in VC for neuroscience drugs, indicating strategic investments.
3. J&J to retain 9.5% stake in Kenvue post-share exchange, showcasing continued interest.
4. Kenvue set to join S&P 500, potentially boosting the stock's market presence.
5. J&J's Kenvue exchange offer was too popular, which could result in positive market sentiment.
### Risks:
1. J&J's vaccine division to close part, potential impact on business operations.
2. Legal actions and lawsuits regarding drug pricing and litigation concerns.
3. Market volatility and uncertainty affecting healthcare stocks and market technicals.
4. Medical device recall impacting a J&J acquisition, potential business disruption.
5. Risks associated with taxation and proration figure in J&J's exchange offer for Kenvue.
### Score:26
investment score = chances characters count - risks characters count

{{<tradingview symbol="NYSE:JNJ">}}
### References:
- 2023-08-26 [Ken Fisher’s Top 15 Healthcare Stock Picks](https://finance.yahoo.com/news/ken-fisher-top-15-healthcare-142001618.html?.tsrc=rss)
- 2023-08-25 [Novo Nordisk's (NVO) Shares Jump 17% in a Month: Here's Why](https://finance.yahoo.com/news/novo-nordisks-nvo-shares-jump-154100109.html?.tsrc=rss)
- 2023-08-25 [Emergent BioSolutions (EBS) Down 12% in a Week: Here's Why](https://finance.yahoo.com/news/emergent-biosolutions-ebs-down-12-153600729.html?.tsrc=rss)
- 2023-08-25 [J&J’s Kenvue Exchange Offer Was a Big Win for the Little Guy](https://finance.yahoo.com/m/95f75135-612c-34fd-af00-a09a7a1d671e/j%26j%E2%80%99s-kenvue-exchange-offer.html?.tsrc=rss)
- 2023-08-25 [AstraZeneca files lawsuit against U.S. over drug pricing](https://finance.yahoo.com/video/astrazeneca-files-lawsuit-against-u-150733913.html?.tsrc=rss)
- 2023-08-25 [Pro Take: Corporate Venture Capital Provides Path for Long-Term Tech Strategy](https://finance.yahoo.com/m/1db67084-8206-336d-abe0-29535c8da36c/pro-take%3A-corporate-venture.html?.tsrc=rss)
- 2023-08-25 [AARP to join US government in two more lawsuits over Medicare drug pricing negotiations](https://finance.yahoo.com/news/aarp-to-join-us-government-in-two-more-lawsuits-over-medicare-drug-pricing-negotiations-205350458.html?.tsrc=rss)
- 2023-08-24 [CVS Health launches new brand Cordavis to target $100 billion biosimilar market](https://finance.yahoo.com/news/cvs-health-launches-new-brand-cordavis-to-target-100-billion-biosimilar-market-150310022.html?.tsrc=rss)
- 2023-08-24 [5 Defensive Stocks to Buy Amid Lingering Market Volatility](https://finance.yahoo.com/news/5-defensive-stocks-buy-amid-132700943.html?.tsrc=rss)
- 2023-08-24 [UPDATE 2-J&J's Janssen to close part of its vaccine division -Telegraaf](https://finance.yahoo.com/news/1-j-js-janssen-close-163054387.html?.tsrc=rss)


                